Concepts (56)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Bioreactors | 2 | 2026 | 44 | 1.150 |
Why?
|
| Plankton | 1 | 2026 | 6 | 0.960 |
Why?
|
| Gastrointestinal Microbiome | 2 | 2026 | 835 | 0.670 |
Why?
|
| Microbiota | 1 | 2025 | 441 | 0.630 |
Why?
|
| Mucins | 1 | 2026 | 69 | 0.240 |
Why?
|
| Bacterial Adhesion | 1 | 2026 | 104 | 0.230 |
Why?
|
| Leukocyte L1 Antigen Complex | 1 | 2025 | 19 | 0.230 |
Why?
|
| Hydrogels | 1 | 2026 | 101 | 0.220 |
Why?
|
| Biofilms | 1 | 2026 | 98 | 0.220 |
Why?
|
| Phage Therapy | 1 | 2025 | 53 | 0.220 |
Why?
|
| Biosensing Techniques | 1 | 2025 | 75 | 0.210 |
Why?
|
| Callithrix | 1 | 2023 | 14 | 0.210 |
Why?
|
| Dental Caries | 1 | 2023 | 12 | 0.210 |
Why?
|
| Colitis | 1 | 2025 | 159 | 0.200 |
Why?
|
| Probiotics | 1 | 2025 | 231 | 0.190 |
Why?
|
| Receptors, Adrenergic, beta-2 | 1 | 2021 | 57 | 0.170 |
Why?
|
| Adrenergic beta-2 Receptor Agonists | 1 | 2021 | 51 | 0.170 |
Why?
|
| Intestinal Mucosa | 1 | 2026 | 765 | 0.170 |
Why?
|
| Fatty Liver | 1 | 2021 | 220 | 0.150 |
Why?
|
| Glycosides | 1 | 2018 | 10 | 0.140 |
Why?
|
| Triterpenes | 1 | 2018 | 23 | 0.140 |
Why?
|
| Candida glabrata | 1 | 2018 | 18 | 0.140 |
Why?
|
| Candidiasis, Invasive | 1 | 2018 | 23 | 0.130 |
Why?
|
| Inflammation | 1 | 2025 | 1492 | 0.130 |
Why?
|
| Non-alcoholic Fatty Liver Disease | 1 | 2021 | 404 | 0.120 |
Why?
|
| Antifungal Agents | 1 | 2018 | 298 | 0.110 |
Why?
|
| Humans | 4 | 2026 | 131680 | 0.060 |
Why?
|
| Animals | 5 | 2025 | 34375 | 0.050 |
Why?
|
| Bacteriophages | 1 | 2025 | 100 | 0.050 |
Why?
|
| Mice, Inbred C57BL | 2 | 2025 | 4769 | 0.050 |
Why?
|
| Oral Health | 1 | 2023 | 28 | 0.050 |
Why?
|
| RNA, Ribosomal, 16S | 1 | 2023 | 386 | 0.050 |
Why?
|
| Phosphatidate Phosphatase | 1 | 2021 | 2 | 0.040 |
Why?
|
| Formoterol Fumarate | 1 | 2021 | 29 | 0.040 |
Why?
|
| Hepatic Stellate Cells | 1 | 2021 | 28 | 0.040 |
Why?
|
| Disease Models, Animal | 2 | 2025 | 4696 | 0.040 |
Why?
|
| Carnitine | 1 | 2021 | 70 | 0.040 |
Why?
|
| Lipogenesis | 1 | 2021 | 62 | 0.040 |
Why?
|
| Triglycerides | 1 | 2021 | 605 | 0.040 |
Why?
|
| Injections, Intraperitoneal | 1 | 2018 | 66 | 0.030 |
Why?
|
| Lipid Metabolism | 1 | 2021 | 371 | 0.030 |
Why?
|
| Colony Count, Microbial | 1 | 2018 | 87 | 0.030 |
Why?
|
| Mice, Inbred ICR | 1 | 2018 | 152 | 0.030 |
Why?
|
| Placebos | 1 | 2018 | 227 | 0.030 |
Why?
|
| Gene Expression | 1 | 2021 | 1502 | 0.030 |
Why?
|
| Mice | 2 | 2025 | 18488 | 0.030 |
Why?
|
| Aging | 1 | 2023 | 1265 | 0.030 |
Why?
|
| Administration, Oral | 1 | 2018 | 709 | 0.030 |
Why?
|
| Biomarkers | 1 | 2025 | 3405 | 0.030 |
Why?
|
| Liver | 1 | 2021 | 1799 | 0.030 |
Why?
|
| Quality of Life | 1 | 2023 | 2118 | 0.020 |
Why?
|
| Kidney | 1 | 2018 | 1309 | 0.020 |
Why?
|
| Aged | 1 | 2023 | 21261 | 0.010 |
Why?
|
| Male | 2 | 2021 | 65267 | 0.010 |
Why?
|
| Middle Aged | 1 | 2023 | 28889 | 0.010 |
Why?
|
| Treatment Outcome | 1 | 2018 | 12984 | 0.010 |
Why?
|